This week, we received FDA clearance for the triage of Large-Vessel Occlusion (LVO) in head CTA scans, completing the commercial availability of our stroke package and further cementing our comprehensive offering of AI solutions (most comprehensive AI triage suite out there). Combined with our previously-cleared module for Intracranial hemorrhage, health institutions are now able to utilize AI for triage of both ischemic and hemorrhagic stroke in CTs, speeding time to treatment when every second counts.
The news of our recent FDA clearance comes off the heels of the annual RSNA, with a central theme entitled “See Possibilities Together”. I couldn’t think of a better phrase that fits our vision of creating robust AI that works with radiologists, taking real pain points into consideration and creating new clinical workflows around real solutions.
At RSNA 2019, we saw hundreds of AI vendors on display, all sharing fascinating ideas that are pushing the market forward at a rapid pace. Yet, with so many vendors, some focusing on dedicating pathologies, and others, taking a more comprehensive approach, healthcare institutions should be aware of some essential criteria to consider when selecting an AI vendor. And, of course, regulatory clearance being one of the most necessary for swift adoption and deployment.
Seeing deeper: Aidoc’s Complete Stroke Package
Since deploying Aidoc’s complete stroke package, we’ve worked diligently with our clinical partners to achieve the highest level of patient care, showing outcomes beyond the hype – and into the future of an AI-driven workflow.
Aidoc’s Always-on solution continuously scans images for both ischemic and hemorrhagic stroke, automatically and instantly flagging suspected cases in the radiologists’ worklists. Aidoc’s integrated solution provides a single context for radiologists to diagnose both LVO and hemorrhage, so they can quickly decide whether to escalate a case to a specialist stroke center for the most appropriate course of treatment.
Communication is of the utmost importance when it comes to stroke treatment. Aidoc’s solutions allow for timely and convenient review of patients’ NCCT and CTA scans, as well as the ability to expand communication between institutions, thus leveling the standard of assessment and diagnosis within the network. Ultimately, clinicians can rest assured that a unified platform is helping them reduce outliers in treatment while improving communication.
Additionally, the solutions expedite care by notifying radiologists immediately, thereby shaving time off the diagnosis while maintaining a high level of quality at the same time. Here’s just one example of what the stroke workflow looks like with Aidoc’s AI showing an impact in areas such as eligibility for tPA and eligibility for thrombectomy.
By shortening both door to needle and in turn, door to thrombectomy time, AI has the ability to positively impact the functional independence scores of patients who suffer from a stroke. As noted in this recent JAMA study, the magnitude of the association between treatment time and outcomes is clinically meaningful.
Research performed by the University of Rochester Medical Center showed Aidoc’s ability to reduce turnaround time for emergency room patients with intracranial hemorrhage by 36.6%. Research by Yale-New Haven Hospital confirmed Aidoc’s impact in expediting the time to treatment for these critical cases.
The FDA decision is Aidoc’s fourth 501(k) clearance. Our FDA-cleared AI solutions for flagging pulmonary embolism, cervical spine fractures and intracranial hemorrhage are in full clinical and commercial use in more than 300 medical centers across the world.
A leader in AI healthcare, Aidoc is one of Time Magazine’s 50 Genius Companies and its founders were recognized in Forbes’ “30 under 30” list. The company’s solutions analyze medical imaging to provide the most comprehensive solution AI offering in the field. Aidoc is used by radiologists worldwide, aiding them in maximizing their clinical performance and expediting patient care.
In 2019, Aidoc’s pulmonary embolism solution won the “Best New Radiology Software” Minnie award. Aidoc is currently deployed across five continents and has analyzed more than 3.2 million scans in clinical workflows.